16-88643349-GAGGTCACACGACCT-G
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2
The NM_000101.4(CYBA):c.578_*3delAGGTCGTGTGACCT(p.Glu193fs) variant causes a frameshift, stop lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000734 in 1,362,750 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000101.4 frameshift, stop_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYBA | NM_000101.4 | c.578_*3delAGGTCGTGTGACCT | p.Glu193fs | frameshift_variant, stop_lost | Exon 6 of 6 | ENST00000261623.8 | NP_000092.2 | |
CYBA | NM_000101.4 | c.561_*3delAGGTCGTGTGACCT | 3_prime_UTR_variant | Exon 6 of 6 | ENST00000261623.8 | NP_000092.2 | ||
CYBA | XM_011522905.4 | c.*1803_*1816delAGGTCGTGTGACCT | 3_prime_UTR_variant | Exon 6 of 6 | XP_011521207.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYBA | ENST00000261623.8 | c.578_*3delAGGTCGTGTGACCT | p.Glu193fs | frameshift_variant, stop_lost | Exon 6 of 6 | 1 | NM_000101.4 | ENSP00000261623.3 | ||
CYBA | ENST00000261623 | c.561_*3delAGGTCGTGTGACCT | 3_prime_UTR_variant | Exon 6 of 6 | 1 | NM_000101.4 | ENSP00000261623.3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 7.34e-7 AC: 1AN: 1362750Hom.: 0 AF XY: 0.00000149 AC XY: 1AN XY: 671180
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative Uncertain:1
This sequence change disrupts the translational stop signal of the CYBA mRNA. It is expected to extend the length of the CYBA protein by 11 additional amino acid residues. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with CYBA-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.